<-- Back to proposed bills
Health Update
12 December 2022
Type
Written Ministerial Statement
Department
Department of Health and Social Care
At a Glance
Issue Summary
The statement provides an update on progress made in implementing recommendations from the Independent Medicines and Medical Devices Safety Review.
Action Requested
The minister announces several initiatives including the appointment of a Patient Safety Commissioner, expansion of specialist mesh centres for pelvic mesh patients, and new measures to reduce sodium valproate exposure during pregnancy. The government also aims to enhance medical device information systems through outcome registries and is piloting declaration of doctor's interests.
Key Facts
- Dr Henrietta Hughes appointed as the first Patient Safety Commissioner in July 2022.
- Ninth specialist mesh centre opened in Bristol in April 2022, providing access to support services for over 1,900 patients by October 2022.
- Sodium valproate prescribing reduced from 68 women in 2018 to 17 in 2022 due to safety measures and the Pregnancy Prevention Programme.
- CHM recommends two specialists should independently consider sodium valproate prescriptions starting over the coming months.
- Medical device information system aims to increase coverage of outcome registries from 15% to 80% for high-risk procedures by 2025.
- Pilot phase for declaration of doctor's interests in NHS and independent settings; full implementation planned for 2023.
▸
Assessment & feedback
Summary accuracy